{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:19:07Z","timestamp":1794590347617,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xcrm.2024.101592","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:18:13Z","timestamp":1717604293000},"page":"101592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML"],"prefix":"10.1016","volume":"5","author":[{"given":"He-Zhou","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-He","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Xuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101592_bib1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"L\u00fcbbert","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101592_bib2","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","article-title":"Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia","volume":"30","author":"Kantarjian","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101592_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101592_bib4","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101592_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3324\/haematol.2013.099549","article-title":"Why methylation is not a marker predictive of response to hypomethylating agents","volume":"99","author":"Voso","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2024.101592_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib10","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.18632\/oncotarget.1542","article-title":"Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine","volume":"4","author":"Wrangle","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2024.101592_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bjh.16228","article-title":"Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML","volume":"188","author":"Zhao","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2024.101592_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101592_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2019-122896","volume":"134","author":"Silverman","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101592_bib14","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1002\/ajh.26043","article-title":"A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia","volume":"96","author":"Zheng","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2024.101592_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8(+) T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101592_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2024.101592_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s42255-022-00588-8","article-title":"Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited","volume":"4","author":"Li","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2024.101592_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","article-title":"A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03baB signaling","volume":"4","author":"Altea-Manzano","year":"2023","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2024.101592_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101592_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T\u00a0cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101592_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T\u00a0cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101592_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T\u00a0cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101592_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, Diabetes, and Increased Cancer Progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.xcrm.2024.101592_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2024.101592_bib27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2024.101592_bib28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101592_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101592_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2013.11.021","article-title":"Proatherogenic conditions promote autoimmune T helper 17 cell responses in\u00a0vivo","volume":"40","author":"Lim","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101592_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113112","article-title":"IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia","volume":"415","author":"Zhang","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.xcrm.2024.101592_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1194\/jlr.M600255-JLR200","article-title":"Importance of the carboxyl terminus of FAT\/CD36 for plasma membrane localization and function in long-chain fatty acid uptake","volume":"48","author":"Eyre","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.xcrm.2024.101592_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/2643-3230.BCD-19-0077","article-title":"Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia","volume":"1","author":"Zhang","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101592_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.2012.44.3184","article-title":"Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study","volume":"31","author":"Li","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101592_bib35","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101592_bib36","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2011-11-391722","article-title":"Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase\/gp91(phox) expression and the PARP-1\/PAR pathway of apoptosis","volume":"119","author":"Aurelius","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101592_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41589-021-00785-8","article-title":"ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth","volume":"17","author":"Remsberg","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2024.101592_bib38","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood.2021011582","article-title":"Depalmitoylation rewires FLT3-ITD signaling and exacerbates leukemia progression","volume":"138","author":"Lv","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101592_bib39","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200411","article-title":"Protein S-palmitoylation in immunity","volume":"11","author":"Das","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.xcrm.2024.101592_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41589-019-0344-0","article-title":"Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation","volume":"15","author":"Kim","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2024.101592_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature04369","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of\u00a0TRAF3 and TRAF6","volume":"439","author":"Hacker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101592_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/383178a0","article-title":"Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization","volume":"383","author":"Farrar","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101592_bib43","doi-asserted-by":"crossref","first-page":"21278","DOI":"10.1074\/jbc.M002532200","article-title":"Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha","volume":"275","author":"Pando","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101592_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2018.10.034","article-title":"Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-kappaB Activation and PD-L1 Expression","volume":"73","author":"Jin","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2018.07.047","article-title":"Transcription Elongation Can Affect Genome 3D Structure","volume":"174","author":"Heinz","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101592_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T\u00a0cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101592_bib47","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-019-11274-x","article-title":"ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy","volume":"10","author":"Tian","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101592_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071622","article-title":"Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation","volume":"20","author":"Yin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101592_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nchembio.1367","article-title":"Niche-based screening identifies small-molecule inhibitors of leukemia stem cells","volume":"9","author":"Hartwell","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2024.101592_bib50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The\u00a0Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101592_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.gene.2018.06.101","article-title":"Hypermethylated CD36 gene affected the progression of lung cancer","volume":"678","author":"Sun","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.xcrm.2024.101592_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12920-022-01337-2","article-title":"Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females","volume":"15","author":"Tour\u00e9","year":"2022","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.xcrm.2024.101592_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101592_bib54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmet.2018.03.014","article-title":"Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism","volume":"27","author":"Lancaster","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101592_bib55","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1016\/S0002-9343(98)00038-2","article-title":"Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials","volume":"104","author":"Eisenberg","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xcrm.2024.101592_bib56","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s43018-021-00262-0","article-title":"LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-\u03baB signaling axis","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Can. (Ott.)"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:14:11Z","timestamp":1718990051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124002842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666379124002842"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101592","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101592"}}